- Home
- DNLI vs GPI Comparison
DNLI vs GPI Comparison
Compare DNLI & GPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | GPI |
|---|---|---|
| Founded | 2013 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.9B |
| IPO Year | 2017 | 1997 |
Fundamental Metrics
Financial Performance| Metric | DNLI | GPI |
|---|---|---|
| Price | $25.83 | $288.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | $34.33 | ★ $447.14 |
| AVG Volume (30 Days) | ★ 2.0M | 200.2K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 10.85 |
| Revenue | N/A | ★ $11,123,721,000.00 |
| Revenue This Year | N/A | $3.41 |
| Revenue Next Year | $408.85 | $3.10 |
| P/E Ratio | ★ N/A | $26.58 |
| Revenue Growth | N/A | ★ 2.17 |
| 52 Week Low | $12.58 | $279.10 |
| 52 Week High | $26.80 | $488.39 |
Technical Indicators
Market Signals| Indicator | DNLI | GPI |
|---|---|---|
| Relative Strength Index (RSI) | 74.24 | 32.96 |
| Support Level | $18.07 | N/A |
| Resistance Level | N/A | $346.25 |
| Average True Range (ATR) | 1.15 | 11.19 |
| MACD | 0.24 | -2.75 |
| Stochastic Oscillator | 83.50 | 17.28 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About GPI Group 1 Automotive Inc.
Group 1 owns and operates 32 collision centers and 253 automotive dealerships in the US and the UK, offering 36 brands of automobiles altogether. Slightly over half of the stores are in the US with locations mostly in metropolitan areas in 17 states in the Northeast, Southeast, Midwest, and California. Texas alone contributed 31.6% of new-vehicle unit volume in 2025 and the UK 27.6%. Texas, Massachusetts, and California combined was 45.4%. Revenue in 2025 totaled $22.6 billion. The firm entered the UK in 2007 and has 110 stores there contributing about 26% of total revenue. Group 1 was founded in 1995 and is based in Houston.